GlassScriptPhysician profile
Aylon Y Glaser
NPI 1598938433
$906.59
in general payments reported to CMS, 2019-2025
19 companies · $226 in 2025
The $226 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $217 · 2020: $73.61 · 2021: $86.92 · 2022: $106 · 2023: $80.90 · 2024: $117 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $424.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $423.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $211.44 | 2019-2025 | Nucala, Trelegy Ellipta |
| Genzyme Corporation | $193.53 | 2019-2025 | |
| Stryker Corporation | $81.96 | 2019-2025 | Scopis Ent |
| Optinose US, INC. | $57.99 | 2020-2025 | |
| Alk-Abello, INC | $55.67 | 2019-2021 | |
| Intersect Ent, INC. | $45.50 | 2020-2021 | |
| Ars Pharmaceuticals Operations, INC. | $43.31 | 2025 | Neffy |
| Amgen INC. | $28.93 | 2022 | |
| Aerin Medical INC. | $24.46 | 2024 | |
| Kaleo, INC. | $23.68 | 2019-2022 | |
| Inspire Medical Systems, INC. | $21.40 | 2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $18.09 | 2025 | Dupixent |
| Hikma Pharmaceuticals USA | $16.99 | 2025 | Ryaltris |
| Acclarent, INC | $16.98 | 2024 | Acclarent Aera |
| Novartis Pharmaceuticals Corporation | $16.03 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Behring | $15.43 | 2020 | |
| Shire North American Group INC | $14.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.55 | 2019 | |
| Glenmark Therapeutics INC. | $7.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aylon Glaser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.